Ausdal Financial Partners, Inc. Novartis Ag Transaction History

Ausdal Financial Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $453,303 - $504,751	-6,154 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$66.94 - $77.43 $130,800 - $151,298	1,954 Added 46.52%	6,154 $530,000
Q2 2018 Aug 08, 2018	BUY	$64.91 - $73.36 $23,886 - $26,996	368 Added 9.6%	4,200 $317,000
Q1 2018 Apr 20, 2018	BUY	$70.39 - $84.15 $47,724 - $57,053	678 Added 21.5%	3,832 $310,000
Q4 2017 Feb 08, 2018	BUY	$72.33 - $77.64 $25,532 - $27,406	353 Added 12.6%	3,154 $265,000
Q3 2017 Oct 31, 2017	BUY	$74.14 - $77.27 $207,666 - $216,433	2,801	2,801 $240,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.